Intercept Pharmaceuticals Inc (ICPT) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Intercept Pharmaceuticals inc   (NASDAQ: ICPT)


Intercept Pharmaceuticals Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Intercept Pharmaceuticals Inc's ROI in the third quarter of 2023?
Intercept Pharmaceuticals Inc recorded a cumulative net loss of $-62 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -20.19%.

Within the Healthcare sector 345 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2023 from 55 to 3438.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM -12.66 % -12.71 % -11.17 % -8.74 % -8.81 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 302 298 297 324 338
Return On Investment (TTM) -20.19 % 66.44 % 63.41 % 65.19 % 59.07 %
ICPT's Overall Ranking # 3438 # 55 # 58 # 35 # 0
Seq. Investment Change TTM -2.83 % -3.8 % -4.07 % -2.62 % -2.88 %
Seq. Net Income Change TTM - 0.8 % -6.7 % 7.49 % -
Net Income (TTM) in Millions -62 209 207 222 206

ICPT Company Profile >> Back to ICPT Roi Comparisons >> See Annual ICPT Return On Investment



Return On Investment ICPT's Ranking
Within: No.
Industry # 129
Sector # 346
Overall # 3438

Return On Investment Statistics
High Average Low
66.44 %
-51.09 %
-240.39 %
(Jun 30 2023)   (June 30. 2014)







Financial Statements
Intercept Pharmaceuticals Inc's III. Quarter Investments $ 302 Millions ICPT's Balance sheet
Intercept Pharmaceuticals Inc's III. Quarter Income $ -3 Millions Quarterly ICPT's Income Statement
ICPT's Income by Division See ICPT's Income by Division


ICPT Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 324 360 401 593 395
Y / Y Investment Growth -10.15 % -10.27 % -32.29 % 50.11 % 3.85 %
Net Income in Millions 222 -91 -275 -345 -309
Y / Y Net Income Growth - - - - -
Annual Return On Investment 68.54 % -25.38 % -68.48 % -58.14 % -78.3 %


Annual Roi Comment
In the fiscal year 2022 ROI improved to 68.54 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ICPT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ICPT's Competitors
Subscribers only: Roi for Intercept Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for ICPT's Customers

Other Ratios
ICPT's Roa ICPT's Inventory Turnover Ratio ICPT's Growth Rates ICPT's Dividend Statistics
ICPT's Profitability Ratios ICPT's Asset Turnover Ratio ICPT's Dividend Growth
ICPT's Roe ICPT's Valuation Ratios ICPT's Financial Strength Ratios ICPT's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.